Registry of Secondary Revascularization
REVASEC
Multicenter Registry of Secondary Revascularization
1 other identifier
observational
869
1 country
1
Brief Summary
The study will evaluate patients with, at least, one previous procedure of coronary revascularization (surgical, percutaneous or both), that are referred for a new, clinically indicated, diagnostic coronary angiography, to describe their clinical characteristics, management, and prognosis, and will propose a prognosis-oriented classification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2017
CompletedFirst Posted
Study publicly available on registry
November 21, 2017
CompletedStudy Start
First participant enrolled
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedApril 24, 2025
April 1, 2025
3.5 years
November 11, 2017
April 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-oriented composite endpoint
Composite endpoint including: all-cause death, any myocardial infarction or any new unplanned revascularization
1 year
Secondary Outcomes (5)
Rates of individual components of primary outcome
1 to 5 years
Composite endpoint at 2 to 5 years
2 to 5 years
Rate of failure of previous revascularization
baseline (assessed at index catheterization)
Recurrent angina (CCS class, patients reported)
1 to 5 years
Feasibility of secondary revascularization
per protocol, 1 month after index catheterization
Eligibility Criteria
Patients with at least one previous coronary revascularization undergoing a clinically indicated diagnostic coronary angiography
You may qualify if:
- Age ≥ 18 years
- Previous successful coronary revascularization, either percutaneous or surgical, in at least one vessel with diameter ≥2 mm
- Previous successful coronary revascularization must have been successful in at least one vessel and the patient must have been discharged after the previous revascularization
- Clinically indicated diagnostic coronary angiography
- Provide written informed consent
You may not qualify if:
- Inability or refusal to provide written informed consent
- Patient included in any other clinical trial in which the revascularization device is blind to patient or investigator, or is not commercially available
- Insufficient data about previous revascularizations
- Previous revascularization only on vessels of less than 2 mm or which was not successful in any vessel
- Previous percutaneous revascularization with simple plain old balloon angioplasty
- Index coronary angiography indicated as scheduled repeated angiography, planned percutaneous coronary intervention, or pre-surgical angiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital San Carlos, Madridlead
- Laboratorios Farmacéuticos Rovi, S.A.collaborator
- S&H MEDICAL SCIENCE SERVICE, S.L.collaborator
Study Sites (1)
Hospital Clinico San Carlos
Madrid, Madrid, 28005, Spain
Related Publications (2)
Salinas P, Vilchez-Tschischke JP, Noriega F, Macaya F, Rosillo S, Garcia-Camarero T, de la Torre-Hernandez JM, de Tapia B, Jimenez-Kockar M, Regueiro A, Flores-Umanzor E, Garcia-Blas S, Gonzalez-D'Gregorio J, Gomez-Menchero AE, Diaz-Fernandez JF, Rondan J, Amat-Santos I, Ojeda S, Diez-Gil JL, de Miguel Castro A, Lozano Ruiz-Poveda F, Fernandez-Diaz JA, Manzano MC, Cruz-Gonzalez I, Pascual Tejerina V, Garcia Perez-Velasco J, Serra A, Poveda-Andres JL, Macaya C, Escaned J. Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study. Cardiovasc Revasc Med. 2022 Jul;40:50-56. doi: 10.1016/j.carrev.2021.11.015. Epub 2021 Nov 16.
PMID: 34857473BACKGROUNDSalinas P, Garcia-Camarero T, Jimenez-Kockar M, Regueiro A, Garcia-Blas S, Gomez-Menchero AE, Ojeda S, Vilchez-Tschischke JP, Amat-Santos I, Diez-Gil JL, Rondan J, Lozano Ruiz-Poveda F, de Miguel Castro A, Manzano MC, Pascual-Tejerina V, Cruz-Gonzalez I, Garcia Perez-Velasco J, Fernandez-Diaz JA, Escaned J; REVASEC working group (collaborators). Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry. Catheter Cardiovasc Interv. 2023 Oct;102(4):608-619. doi: 10.1002/ccd.30804. Epub 2023 Aug 15.
PMID: 37582340BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pablo Salinas, MD, PhD
Hospital San Carlos, Madrid
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 11, 2017
First Posted
November 21, 2017
Study Start
November 22, 2017
Primary Completion
May 31, 2021
Study Completion
December 15, 2025
Last Updated
April 24, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share